LYR-210 - Business-News-Today.com

Business-News-Today.com

Business news, market intelligence, and global industry analysis.

Business-News-Today.com

The Latest

Representative image illustrating an advanced AI system operating software autonomously, reflecting the Macrohard project unveiled by Tesla, Inc. and xAI, which Elon Musk claims could replicate the full operational functions of software companies using agentic artificial intelligence.

Macrohard : The AI project Musk says no other company can do yet, and what that claim actually means

United Therapeutics (NASDAQ: UTHR) pushes inhaled therapy strategy as Phase 3 Tyvaso data shows lung function preservation in IPF

Representative image illustrating a drone flying over California as reports reveal that Iran allegedly considered a surprise drone strike on targets in the state, according to a Federal Bureau of Investigation intelligence bulletin disclosed during the ongoing United States–Iran conflict.

Iran planned surprise drone strike on California, FBI bulletin reveals

Palantir Technologies (NASDAQ: PLTR) expands Asia enterprise push through LG CNS partnership

What LG CNS and Palantir’s new partnership means for the future of industrial AI adoption

Lyra Therapeutics, Inc. reveals ENLIGHTEN 1 trial results for LYR-210, failing to meet primary endpoints in chronic rhinosinusitis treatment.

Read More

2 minute read

Pharma Industry News

Lyra Therapeutics reports disappointing results for LYR-210 in Phase 3 chronic rhinosinusitis trial

Lyra Therapeutics, Inc. (Nasdaq: LYRA), dedicated to advancing treatments for chronic rhinosinusitis (CRS), announced that its Phase 3…

byPallavi Madhiraju

May 7, 2024

Read More

2 minute read

Pharma Industry News

Lyra Therapeutics raises $30m for chronic rhinosinusitis drug candidates

Lyra Therapeutics has raised $30 million in a Series C financing round to advance its lead product candidates…

bypharmanewsdaily

February 1, 2020

web analytics